文献速递其他结缔组织病

白细胞介素-2相关调节性CD4+ T细胞缺陷在系统性硬化症小鼠模型肺纤维化及血管重塑中的驱动作用

Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2022-06-28

本研究在Fra-2转基因系统性硬化症小鼠模型中,用多色流式细胞术分析外周CD4+ T细胞稳态与表型,并测试过继转移调节性T细胞、低剂量白细胞介素-2(IL-2)及联合治疗的效果。结果显示小鼠存在外周调节性T细胞比例与绝对数显著下降,且早于活化Th2极化CD4+ T细胞积聚;上述治疗可显著减少肺实质纤维化与肺血管重塑。作者认为恢复调节性T细胞稳态的免疫治疗可能对系统性硬化症有意义。

要点

  • Fra-2转基因小鼠外周调节性T细胞比例与绝对数显著下降,早于活化Th2极化CD4+ T细胞积聚。
  • 调节性T细胞缺陷源于胸腺与外周生成受损,以及外周常规CD4+ T细胞产生IL-2能力受损。
  • 过继转移调节性T细胞、低剂量IL-2或联合治疗均显著减少肺实质纤维化与肺血管重塑。

核心结论

  • 作者认为,恢复调节性T细胞稳态的免疫治疗可能对系统性硬化症有意义。
  • 作者认为,基于低剂量IL-2注射的干预(已在其他自身免疫病中提出)可能是未来研究中恢复调节性T细胞稳态最合适的治疗方式。

研究设计与样本

  • 研究使用Fra-2转基因小鼠模型与对照小鼠,采用多色流式细胞术广泛表征外周CD4+ T细胞稳态与表型。
  • 研究测试了过继转移调节性T细胞、低剂量白细胞介素-2(IL-2)治疗及联合治疗对恢复调节性T细胞稳态的效果。

主要发现

  • Fra-2转基因小鼠外周调节性T细胞比例与绝对数显著下降,且早于活化、Th2极化的CD4+ T细胞积聚。
  • 调节性T细胞稳态缺陷源于胸腺与外周生成受损的组合机制;外周常规CD4+ T细胞产生IL-2能力受损可能极大促进调节性T细胞缺陷。
  • 过继转移调节性T细胞、低剂量IL-2治疗或联合治疗改变了Fra-2转基因小鼠表型,使肺实质纤维化与肺血管重塑显著减少。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic sclerosis (SSc) is a debilitating autoimmune disease characterized by severe lung outcomes resulting in reduced life expectancy. Fra-2-transgenic mice offer the opportunity to decipher the relationships between the immune system and lung fibrosis. This study was undertaken to investigate whether the Fra-2-transgenic mouse lung phenotype may result from an imbalance between the effector and regulatory arms in the CD4+ T cell compartment. METHODS: We first used multicolor flow cytometry to extensively characterize homeostasis and the phenotype of peripheral CD4+ T cells from Fra-2-transgenic mice and control mice. We then tested different treatments for their effectiveness in restoring CD4+ Treg cell homeostasis, including adoptive transfer of Treg cells and treatment with low-dose interleukin-2 (IL-2). RESULTS: Fra-2-transgenic mice demonstrated a marked decrease in the proportion and absolute number of peripheral Treg cells that preceded accumulation of activated, T helper cell type 2-polarized, CD4+ T cells. This defect in Treg cell homeostasis was derived from a combination of mechanisms including impaired generation of these cells in both the thymus and the periphery. The impaired ability of peripheral conventional CD4+ T cells to produce IL-2 may greatly contribute to Treg cell deficiency in Fra-2-transgenic mice. Notably, adoptive transfer of Treg cells, low-dose IL-2 therapy, or combination therapy changed the phenotype of Fra-2-transgenic mice, resulting in a significant reduction in pulmonary parenchymal fibrosis and vascular remodeling in the lungs. CONCLUSION: Immunotherapies for restoring Treg cell homeostasis could be relevant in SSc. An intervention based on low-dose IL-2 injections, as is already proposed in other autoimmune diseases, could be the most suitable treatment modality for restoring Treg cell homeostasis for future research.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Frantz C, Cauvet A, Durand A, et al. Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis. Arthritis Rheumatol. 2022. PMID: 35255201. doi:10.1002/art.42111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。